The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination - Test2 - elhamkhani - TriplyDB

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

http://www.wikidata.org/entity/Q28201717

about

sameAs

Deubiquitylating enzymes and disease The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2 TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8 The deubiquitinating enzyme CYLD controls apical docking of basal bodies in ciliated epithelial cells Emerging roles for the non-canonical IKKs in cancer The tumor suppressor CYLD regulates entry into mitosis USP13 enzyme regulates Siah2 ligase stability and activity via noncatalytic ubiquitin-binding domains NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways K63-specific deubiquitination by two JAMM/MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1 The IkappaB kinase complex: master regulator of NF-kappaB signaling CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1 Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6 Distinct regulation of Ubc13 functions by the two ubiquitin-conjugating enzyme variants Mms2 and Uev1A Regulation of MITF stability by the USP13 deubiquitinase USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity Agonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulation Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB Pathogen recognition and inflammatory signaling in innate immune defenses Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor Post-translational modifications as key regulators of TNF-induced necroptosis Poly-ubiquitination in TNFR1-mediated necroptosis Hypoxia Induced NF-κB Ubiquitylation as a Rheostat for TCR Signaling: From Targeted Approaches Toward Global Profiling Regulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULIN Molecular basis of hypohidrotic ectodermal dysplasia: an update Roles of miR-182 in sensory organ development and cancer When ubiquitin meets NF-κB: a trove for anti-cancer drug development Ubiquitin in the immune system Regulation of NF-κB by ubiquitination

P2860

Q21284381-21954047-26B4-461B-A433-20D6BFCF972B Q24294960-4B23D6C9-1D09-4F89-9787-00CE8D7C1DA6 Q24296068-5C6BBAE2-A3C6-4F55-8AF4-675400D483AD Q24296502-93D8EAED-452F-4D60-B37C-86661BBC3DAA Q24297399-FBCBAE91-2A2E-4826-8483-616B45B0DB58 Q24299892-F55E3EF0-0968-4D03-A0C6-FC295546C16C Q24300971-3BD476F6-E6A8-4C3F-9D6E-DBE23CEA0C8D Q24301536-1B35A50C-EDDE-4514-921F-4BBBD25328A6 Q24302203-7E691886-6F17-4E7C-8616-F83A587971E9 Q24305225-FA7E8187-8365-4D4C-8E9C-A65F4730C4D9 Q24305326-F817D47A-9BDA-4B4A-BECC-27026307068D Q24306252-2B549C42-BEC1-4928-A21E-DB6BFFF3003D Q24309046-1BE88B6B-6B51-49FC-9059-49BCE2FB65A6 Q24310641-26204FAB-832E-41F9-95D5-CA94086C3C77 Q24313366-2595440F-074F-4EA2-91D0-36D0C614B919 Q24314876-318C338F-A212-4663-BB82-89A20836D246 Q24314946-99B707A9-9AA0-4CC7-B003-C62E4A0C7C3D Q24315115-9A77D44B-66B3-4ADD-AE69-A8855446A778 Q24318345-B8398D09-53B5-43BD-9331-35672277834B Q24318789-4CF0D10E-3676-44A2-BAAE-C38009AF2C4C Q24318832-295FD24F-C23B-4410-9F98-85F987FB7A2E Q24328791-8205AE9F-1915-4ED4-BF7C-770E9906EABF Q24337169-9FFADA54-1D3D-4E0A-8D01-779FCF63752C Q24530708-F227B75E-6B7D-4A31-89C3-52F5161A3897 Q24618315-6CC7F280-75AB-4972-814E-CC14C1C4D173 Q24622802-050721E1-6119-40CA-8BEE-258E755C567A Q24629378-BD7B24E3-9BA4-44C1-9937-155A79F60EC4 Q24643034-8ABA7901-EA32-46AA-BDEA-E31EABA306E7 Q24645701-97463D0B-E741-4E02-A774-65A63EC3778A Q24672820-3B5F66D6-E578-40D1-81B5-86DE0EF03419 Q26744244-16E7F772-FE04-4C90-B313-2E6633722E22 Q26749315-0E6854E0-44BC-45D0-B8EB-C5056C212B39 Q26752556-CFBA5DAE-986C-4032-8AB2-C9C008DF7DFA Q26770849-18196E08-678E-44EF-AAF2-3C76E5629001 Q26778774-9F7FDE83-CB36-47A7-996D-07E5756343DD Q26796229-12A1066D-9818-4705-9C72-7B78F55FB4E9 Q26798264-87C0A890-49D4-46A4-90B9-C466757B3B57 Q26827754-8C79F7EC-4B43-4B1A-9AB9-389635374237 Q26998711-8B004CAE-B753-4110-B182-5BF3A16DB2B4 Q27024099-989FB8D4-6488-4BAD-A3D5-571CE80B0B6E

P2860

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

http://www.wikidata.org/entity/Q28201717

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@ast

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@en

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@nl

type

label

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@ast

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@en

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@nl

prefLabel

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@ast

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@en

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@nl

P1433

Q28201717-39ADC918-8D07-4411-86B7-1069D28A816D

P1476

Q28201717-9942B594-6037-454D-BE72-83C15463701D

P2093

Q28201717-19339746-1121-4047-8F57-95FDBB0A3D10

Q28201717-263BAF31-BBF3-4E8F-8EA9-D360BE049671

Q28201717-2B1F1600-BF14-41B8-846D-899D71E0E720

Q28201717-3FD33E97-84A8-40AD-B19F-E4B7DD77E10B

Q28201717-84F2AD46-3853-490F-A82D-7FB07F2A2077

Q28201717-BB9A19FA-F4FF-44FF-B037-D6F0649CCE80

P2888

Q28201717-C60587B2-0E13-4838-AC73-A3FD1EC6B80B

P304

Q28201717-BBA140F1-B227-41FD-B203-8FD13C4DBC16

P31

Q28201717-0EF4BA89-0312-42DC-9F79-CF3DF4613F76

P3181

Q28201717-6982A32B-946A-400B-9B76-F003A6139E5A

P356

Q28201717-23D4649B-FA67-424C-B8E0-C0DBC944B73D

P407

Q28201717-96C1A368-244B-4E59-8D8D-1F5B74EC4C81

P433

Q28201717-1C65E9E8-6929-4EA2-A845-5F54C967E161

P478

Q28201717-A5545914-C698-4C6D-9ACB-08DE5580D3CC

P577

Q28201717-92EFD9E5-4589-4123-978E-552FB9BC5070

P5875

Q28201717-3862FBDE-33EC-4573-AC22-BC845B908B4B

P6179

Q28201717-4307B0D3-2988-40EC-870E-5BDE3B53543D

P698

Q28201717-0CD677C3-EB40-4480-B5A0-4784BDF3E23C

P921

Q28201717-C2ABA0F7-4D97-4158-8B42-6CA1B38B52BF

P3181

P356

P1433

P1476

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

@en

P2093

Alain Israël

http://www.w3.org/2001/XMLSchema#string

Andrew Kovalenko

http://www.w3.org/2001/XMLSchema#string

Christine Chable-Bessia

http://www.w3.org/2001/XMLSchema#string

David Wallach

http://www.w3.org/2001/XMLSchema#string

Gilles Courtois

http://www.w3.org/2001/XMLSchema#string

Giuseppina Cantarella

http://www.w3.org/2001/XMLSchema#string

P2888

P304

801-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1252006

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE01802

http://www.w3.org/2001/XMLSchema#string

P407

P433

6950

http://www.w3.org/2001/XMLSchema#string

P478

424

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10613897

http://www.w3.org/2001/XMLSchema#string

P6179

1010362117

http://www.w3.org/2001/XMLSchema#string

P698

12917691

http://www.w3.org/2001/XMLSchema#string

P921